Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Oncology Research and Treatment|January 24, 2024
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of PhysiciansSascha Eickmann, Daniel Wolff, Guido Kobbe, et al.
Annals of Hematology|March 29, 2012
Hereditary thrombocythemia caused by a thrombopoietin (THPO) gain-of-function mutation associated with multiple myeloma and congenital limb defectsClemens Stockklausner, Nicole Echner, Anne-Christine Klotter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2020
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?Peter Dreger, Timothy S Fenske, Silvia Montoto, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2025
Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantationMatthias Limbach, Rea Kuehl, Maximilian Koeppel, et al.
BMC Cancer|September 9, 2015
Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cell transplantationJoachim Wiskemann, Rea Kuehl, Peter Dreger, et al.
Bone Marrow Transplantation|June 10, 2018
High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working PartyStephen Paul Robinson, Ariane Boumendil, Herve Finel, et al.
Thescientificworldjournal|June 6, 2012
CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantationJolanta B Perz, Selma Gürel, Stefan O Schonland, et al.
Leukemia & Lymphoma|May 10, 2013
Unrelated and alternative donor allogeneic stem cell transplant in patients with relapsed or refractory Hodgkin lymphoma: a systematic reviewMelanie Messer, Andrea Steinzen, Elke Vervölgyi, et al.
Cancers|October 1, 2020
Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell TransplantationAleksandar Radujkovic, Lambros Kordelas, Rashit Bogdanov, et al.
Cancer Chemotherapy and Pharmacology|July 21, 2014
In vitro testing of drug combinations employing nilotinib and alkylating agents with regard to pretransplant conditioning treatment of advanced-phase chronic myeloid leukemiaAleksandar Radujkovic, Thomas Luft, Peter Dreger, et al.
Pageof 32